International peritoneal dialysis training practices and the risk of peritonitis.


Journal

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402

Informations de publication

Date de publication:
25 04 2022
Historique:
received: 24 05 2021
pubmed: 12 10 2021
medline: 27 4 2022
entrez: 11 10 2021
Statut: ppublish

Résumé

The effects of training practices on outcomes of patients receiving peritoneal dialysis (PD) are poorly understood and there is a lack of evidence informing best training practices. This prospective cohort study aims to describe and compare international PD training practices and their association with peritonitis. Adult patients on PD <3 months participating in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) were included. Training characteristics (including duration, location, nurse affiliation, modality, training of family members, use of individual/group training and use of written/oral competency assessments) were reported at patient and facility levels. The hazard ratio (HR) for time to first peritonitis was estimated using Cox models, adjusted for selected patient and facility case-mix variables. A total of 1376 PD patients from 120 facilities across seven countries were included. Training was most commonly performed at the facility (81%) by facility-affiliated nurses (87%) in a 1:1 setting (79%). In the UK, being trained by both facility and third-party nurses was associated with a reduced peritonitis risk [adjusted HR 0.31 (95% confidence interval 0.15-0.62) versus facility nurses only]. However, this training practice was utilized in only 5 of 14 UK facilities. No other training characteristics were convincingly associated with peritonitis risk. There was no evidence to support that peritonitis risk was associated with when, where, how or how long PD patients are trained.

Sections du résumé

BACKGROUND
The effects of training practices on outcomes of patients receiving peritoneal dialysis (PD) are poorly understood and there is a lack of evidence informing best training practices. This prospective cohort study aims to describe and compare international PD training practices and their association with peritonitis.
METHODS
Adult patients on PD <3 months participating in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) were included. Training characteristics (including duration, location, nurse affiliation, modality, training of family members, use of individual/group training and use of written/oral competency assessments) were reported at patient and facility levels. The hazard ratio (HR) for time to first peritonitis was estimated using Cox models, adjusted for selected patient and facility case-mix variables.
RESULTS
A total of 1376 PD patients from 120 facilities across seven countries were included. Training was most commonly performed at the facility (81%) by facility-affiliated nurses (87%) in a 1:1 setting (79%). In the UK, being trained by both facility and third-party nurses was associated with a reduced peritonitis risk [adjusted HR 0.31 (95% confidence interval 0.15-0.62) versus facility nurses only]. However, this training practice was utilized in only 5 of 14 UK facilities. No other training characteristics were convincingly associated with peritonitis risk.
CONCLUSIONS
There was no evidence to support that peritonitis risk was associated with when, where, how or how long PD patients are trained.

Identifiants

pubmed: 34634100
pii: 6388401
doi: 10.1093/ndt/gfab298
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

937-949

Subventions

Organisme : AHRQ HHS
ID : R01 HS025756
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the ERA.

Auteurs

Melissa S Cheetham (MS)

Department of Nephrology, Sunshine Coast University Hospital, Birtinya, QLD, Australia.
Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
Sunshine Coast Health Institute, Birtinya, QLD, Australia.

Junhui Zhao (J)

Arbor Research Collaborative for Health, Ann Arbor, MI, USA.

Keith McCullough (K)

Arbor Research Collaborative for Health, Ann Arbor, MI, USA.

Douglas S Fuller (DS)

Arbor Research Collaborative for Health, Ann Arbor, MI, USA.

Yeoungjee Cho (Y)

Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Australasian Kidney Trials Network, University of Queensland, Brisbane, QLD, Australia.
Translational Research Institute, Brisbane, QLD, Australia.

Rathika Krishnasamy (R)

Department of Nephrology, Sunshine Coast University Hospital, Birtinya, QLD, Australia.
Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.

Neil Boudville (N)

Department of Nephrology, Sir Charles Gairdner Hospital, Perth, WA, Australia.
Medical School, University of Western Australia, Perth, WA, Australia.

Ana E Figueiredo (AE)

School of Health Sciences and Life, Nursing School, Pontificia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.

Yasuhiko Ito (Y)

Aichi Medical University, Nagakute, Japan.

Talerngsak Kanjanabuch (T)

Division of Nephrology, Department of Medicine and Center of Excellence in Kidney Metabolic Disorders, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Jeffrey Perl (J)

Arbor Research Collaborative for Health, Ann Arbor, MI, USA.
St Michael's Hospital, Toronto, ON, Canada.

Beth M Piraino (BM)

University of Pittsburgh, Pittsburgh, PA, USA.

Ronald L Pisoni (RL)

Arbor Research Collaborative for Health, Ann Arbor, MI, USA.

Cheuk C Szeto (CC)

Chinese University of Hong Kong, Shatin, Hong Kong, China.

Isaac Teitelbaum (I)

University of Colorado, Aurora, CO, USA.

Graham Woodrow (G)

Renal Unit, St James's University Hospital, Leeds, UK.

David W Johnson (DW)

Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Australasian Kidney Trials Network, University of Queensland, Brisbane, QLD, Australia.
Translational Research Institute, Brisbane, QLD, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH